COVID-19 Impact on Global Prostate Cancer Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Prostate Cancer Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Prostate Cancer Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Hormone sensitive prostate cancer
  • 1.4.3 Hormone refractory prostate cancer
• 1.5 Market by Application
  • 1.5.1 Global Prostate Cancer Market Share by Application: 2020 VS 2026
  • 1.5.2 Chemotherapy
  • 1.5.3 Hormonal Therapy
  • 1.5.4 Targeted Therapy
  • 1.5.5 Immunotherapy
• 1.6 Coronavirus Disease 2019 (Covid-19): Prostate Cancer Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the Prostate Cancer Industry
    • 1.6.1.1 Prostate Cancer Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and Prostate Cancer Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for Prostate Cancer Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends by Regions

• 2.1 Prostate Cancer Market Perspective (2015-2026)
• 2.2 Prostate Cancer Growth Trends by Regions
  • 2.2.1 Prostate Cancer Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Prostate Cancer Historic Market Share by Regions (2015-2020)
  • 2.2.3 Prostate Cancer Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Prostate Cancer Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Prostate Cancer Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Prostate Cancer Players by Market Size
  • 3.1.1 Global Top Prostate Cancer Players by Revenue (2015-2020)
  • 3.1.2 Global Prostate Cancer Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Prostate Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Prostate Cancer Market Concentration Ratio
  • 3.2.1 Global Prostate Cancer Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Prostate Cancer Revenue in 2019
• 3.3 Prostate Cancer Key Players Head office and Area Served
• 3.4 Key Players Prostate Cancer Product Solution and Service
• 3.5 Date of Enter into Prostate Cancer Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Prostate Cancer Historic Market Size by Type (2015-2020)
• 4.2 Global Prostate Cancer Forecasted Market Size by Type (2021-2026)

5 Prostate Cancer Breakdown Data by Application (2015-2026)

• 5.1 Global Prostate Cancer Market Size by Application (2015-2020)
• 5.2 Global Prostate Cancer Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Prostate Cancer Market Size (2015-2020)
• 6.2 Prostate Cancer Key Players in North America (2019-2020)
• 6.3 North America Prostate Cancer Market Size by Type (2015-2020)
• 6.4 North America Prostate Cancer Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Prostate Cancer Market Size (2015-2020)
• 7.2 Prostate Cancer Key Players in Europe (2019-2020)
• 7.3 Europe Prostate Cancer Market Size by Type (2015-2020)
• 7.4 Europe Prostate Cancer Market Size by Application (2015-2020)

8 China

• 8.1 China Prostate Cancer Market Size (2015-2020)
• 8.2 Prostate Cancer Key Players in China (2019-2020)
• 8.3 China Prostate Cancer Market Size by Type (2015-2020)
• 8.4 China Prostate Cancer Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Prostate Cancer Market Size (2015-2020)
• 9.2 Prostate Cancer Key Players in Japan (2019-2020)
• 9.3 Japan Prostate Cancer Market Size by Type (2015-2020)
• 9.4 Japan Prostate Cancer Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Prostate Cancer Market Size (2015-2020)
• 10.2 Prostate Cancer Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Prostate Cancer Market Size by Type (2015-2020)
• 10.4 Southeast Asia Prostate Cancer Market Size by Application (2015-2020)

11 India

• 11.1 India Prostate Cancer Market Size (2015-2020)
• 11.2 Prostate Cancer Key Players in India (2019-2020)
• 11.3 India Prostate Cancer Market Size by Type (2015-2020)
• 11.4 India Prostate Cancer Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Prostate Cancer Market Size (2015-2020)
• 12.2 Prostate Cancer Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Prostate Cancer Market Size by Type (2015-2020)
• 12.4 Central & South America Prostate Cancer Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Astellas, Inc.
  • 13.1.1 Astellas, Inc. Company Details
  • 13.1.2 Astellas, Inc. Business Overview and Its Total Revenue
  • 13.1.3 Astellas, Inc. Prostate Cancer Introduction
  • 13.1.4 Astellas, Inc. Revenue in Prostate Cancer Business (2015-2020))
  • 13.1.5 Astellas, Inc. Recent Development
• 13.2 AstraZeneca plc
  • 13.2.1 AstraZeneca plc Company Details
  • 13.2.2 AstraZeneca plc Business Overview and Its Total Revenue
  • 13.2.3 AstraZeneca plc Prostate Cancer Introduction
  • 13.2.4 AstraZeneca plc Revenue in Prostate Cancer Business (2015-2020)
  • 13.2.5 AstraZeneca plc Recent Development
• 13.3 Johnson & Johnson
  • 13.3.1 Johnson & Johnson Company Details
  • 13.3.2 Johnson & Johnson Business Overview and Its Total Revenue
  • 13.3.3 Johnson & Johnson Prostate Cancer Introduction
  • 13.3.4 Johnson & Johnson Revenue in Prostate Cancer Business (2015-2020)
  • 13.3.5 Johnson & Johnson Recent Development
• 13.4 Sanofi S.A
  • 13.4.1 Sanofi S.A Company Details
  • 13.4.2 Sanofi S.A Business Overview and Its Total Revenue
  • 13.4.3 Sanofi S.A Prostate Cancer Introduction
  • 13.4.4 Sanofi S.A Revenue in Prostate Cancer Business (2015-2020)
  • 13.4.5 Sanofi S.A Recent Development
• 13.5 Bristol Myers Squibb (BMS)
  • 13.5.1 Bristol Myers Squibb (BMS) Company Details
  • 13.5.2 Bristol Myers Squibb (BMS) Business Overview and Its Total Revenue
  • 13.5.3 Bristol Myers Squibb (BMS) Prostate Cancer Introduction
  • 13.5.4 Bristol Myers Squibb (BMS) Revenue in Prostate Cancer Business (2015-2020)
  • 13.5.5 Bristol Myers Squibb (BMS) Recent Development
• 13.6 Bayer AG
  • 13.6.1 Bayer AG Company Details
  • 13.6.2 Bayer AG Business Overview and Its Total Revenue
  • 13.6.3 Bayer AG Prostate Cancer Introduction
  • 13.6.4 Bayer AG Revenue in Prostate Cancer Business (2015-2020)
  • 13.6.5 Bayer AG Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer